DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
AV-380
1
Unknown
Investigational
Unknown
Unknown
Cachexia
Unknown
AV-380
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GANULAMERAN
1
Unknown
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
GANULAMERAN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZB-716
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
ZB-716
×
Maximum Phase:
1
First Approval:
None
UNII:
E35ZN95LMT
Molecule Type:
Small molecule
Molecular Formula:
C32H48BF5O4S
Molecular Weight:
634.6
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
XL-418
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Ribosomal protein S6 kinase (P70S6K) inhibitor
XL-418
×
Maximum Phase:
1
First Approval:
None
UNII:
OLJ18SRI8A
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASTX-029
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
ASTX-029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-8776
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MK-8776
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROCAKINOGENE SIFUPLASMID
1
Gene
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Glioblastoma; Hemorrhagic Fever, Ebola; HIV Infections; Neoplasms; Urinary Bladder Neoplasms
Unknown
ROCAKINOGENE SIFUPLASMID
×
Maximum Phase:
1
First Approval:
None
UNII:
91JHE0ANN8
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LS 11
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LS 11
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAROVASERTIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DAROVASERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
E0YF0M8O09
Molecule Type:
Small molecule
Molecular Formula:
C22H23F3N8O
Molecular Weight:
472.48
AlogP:
3.1
PSA:
135.94
HBD:
3.0
HBA:
#RotB:
4.0
Source:
BENZOYLPHENYLUREA
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
BENZOYLPHENYLUREA
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.26
AlogP:
2.41
PSA:
63.4
HBD:
1.0
HBA:
#RotB:
2.0
Source:
NNZ-2591
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NNZ-2591
×
Maximum Phase:
1
First Approval:
None
UNII:
2T1HU6069S
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O2
Molecular Weight:
194.23
AlogP:
0.05
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
2.0
Source:
AZD-9977
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Heart Failure; Kidney Diseases
Mineralocorticoid receptor modulator
AZD-9977
×
Maximum Phase:
1
First Approval:
None
UNII:
6C9UKZ0CYE
Molecule Type:
Small molecule
Molecular Formula:
C20H18FN3O5
Molecular Weight:
399.38
AlogP:
1.7
PSA:
96.97
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BQ 788
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases
Unknown
BQ 788
×
Maximum Phase:
1
First Approval:
None
UNII:
6MB0YNA8DJ
Molecule Type:
Small molecule
Molecular Formula:
C34H51N5O7
Molecular Weight:
641.81
AlogP:
4.82
PSA:
159.07
HBD:
4.0
HBA:
#RotB:
12.0
Source:
ANX-042
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
ANX-042
×
Maximum Phase:
1
First Approval:
None
UNII:
ZV0MCR055T
Molecule Type:
Protein
Molecular Formula:
C189H312N58O53S4
Molecular Weight:
4373.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TEPOTINIB HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung
Hepatocyte growth factor receptor inhibitor
TEPOTINIB HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
VY5YX2TQ1F
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClN6O3
Molecular Weight:
547.06
AlogP:
4.01
PSA:
96.93
HBD:
0.0
HBA:
#RotB:
7.0
Source:
LU AF-82422
1
Unknown
Investigational
Unknown
Unknown
Parkinson Disease
Unknown
LU AF-82422
×
Maximum Phase:
1
First Approval:
None
UNII:
52V6AS6U0A
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VELSECORAT
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Asthma
Unknown
VELSECORAT
×
Maximum Phase:
1
First Approval:
None
UNII:
P30N0911C2
Molecule Type:
Small molecule
Molecular Formula:
C32H32F2N4O6
Molecular Weight:
606.63
AlogP:
4.6
PSA:
112.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ASTX-660
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma
Unknown
ASTX-660
×
Maximum Phase:
1
First Approval:
None
UNII:
2LHZ9ZC3YO
Molecule Type:
Small molecule
Molecular Formula:
C30H42FN5O3
Molecular Weight:
539.7
AlogP:
2.31
PSA:
81.17
HBD:
2.0
HBA:
#RotB:
7.0
Source:
APVO-436
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
APVO-436
×
Maximum Phase:
1
First Approval:
None
UNII:
DNP8BBW84R
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARC1905
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ARC1905
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-00562271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Focal adhesion kinase 1 inhibitor
PF-00562271
×
Maximum Phase:
1
First Approval:
None
UNII:
K5BX8ZA7UF
Molecule Type:
Small molecule
Molecular Formula:
C21H20F3N7O3S
Molecular Weight:
507.5
AlogP:
3.14
PSA:
129.21
HBD:
3.0
HBA:
#RotB:
7.0
Source:
PHI-101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
PHI-101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H19FN4O2S
Molecular Weight:
386.45
AlogP:
2.26
PSA:
96.25
HBD:
4.0
HBA:
#RotB:
3.0
Source:
ETHASELEN
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
ETHASELEN
×
Maximum Phase:
1
First Approval:
None
UNII:
4Q2EZS1IWG
Molecule Type:
Small molecule
Molecular Formula:
C16H12N2O2Se2
Molecular Weight:
422.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
URB-597
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
URB-597
×
Maximum Phase:
1
First Approval:
None
UNII:
PX47LB88FO
Molecule Type:
Small molecule
Molecular Formula:
C20H22N2O3
Molecular Weight:
338.41
AlogP:
3.87
PSA:
81.42
HBD:
2.0
HBA:
#RotB:
4.0
Source:
KW-2478
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma
Unknown
KW-2478
×
Maximum Phase:
1
First Approval:
None
UNII:
QY50S617NM
Molecule Type:
Small molecule
Molecular Formula:
C30H42N2O9
Molecular Weight:
574.67
AlogP:
2.27
PSA:
127.23
HBD:
2.0
HBA:
#RotB:
16.0
Source:
ERAGIDOMIDE
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
ERAGIDOMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBACYCLIC PHOSPHATIDIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Unknown
CARBACYCLIC PHOSPHATIDIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
OXV962AR86
Molecule Type:
Small molecule
Molecular Formula:
C22H41O5P
Molecular Weight:
416.54
AlogP:
6.4
PSA:
72.83
HBD:
1.0
HBA:
#RotB:
17.0
Source:
GORALATIDE
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
GORALATIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
H041538E9P
Molecule Type:
Protein
Molecular Formula:
C20H33N5O9
Molecular Weight:
487.51
AlogP:
-2.87
PSA:
228.46
HBD:
7.0
HBA:
#RotB:
14.0
Source:
ULILEDLIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
ULILEDLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEXANERSEN
1
Oligonucleotide
Investigational
Unknown
Unknown
Huntington Disease
Unknown
LEXANERSEN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GS-9191
1
Small molecule
Investigational
Unknown
Unknown
Condylomata Acuminata
Unknown
GS-9191
×
Maximum Phase:
1
First Approval:
None
UNII:
5I2GJW5Z2Q
Molecule Type:
Small molecule
Molecular Formula:
C37H51N8O6P
Molecular Weight:
734.84
AlogP:
4.95
PSA:
184.61
HBD:
4.0
HBA:
#RotB:
21.0
Source:
HUPAM4
1
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 binding agent
HUPAM4
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AN-2718
1
Small molecule
Investigational
Unknown
Unknown
Tinea Pedis
Unknown
AN-2718
×
Maximum Phase:
1
First Approval:
None
UNII:
810U6C2DGG
Molecule Type:
Small molecule
Molecular Formula:
C7H6BClO2
Molecular Weight:
168.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CAL-263
1
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
PI3-kinase p110-delta subunit inhibitor
CAL-263
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APOCYNIN
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cardiovascular Diseases; Pulmonary Disease, Chronic Obstructive
Unknown
APOCYNIN
×
Maximum Phase:
1
First Approval:
None
UNII:
B6J7B9UDTR
Molecule Type:
Small molecule
Molecular Formula:
C9H10O3
Molecular Weight:
166.18
AlogP:
1.6
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
2.0
Source:
1
2
…
122
123
124
125
126
127
128
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA